Daré Bioscience publishes Phase 1 sildenafil cream data in men

September 14, 2026 8:50 AM

Daré Bioscience (NASDAQ: DARE) announced the publication of results from a Phase 1 clinical study evaluating the safety and systemic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found